Innovative Stem Cell Microtissues Enable Personalized Drug Testing for Neurodegenerative Diseases
New stem cell-derived microtissues mimicking the human spinal cord offer personalized platforms for drug screening and studying neuroinflammation in ALS, paving the way for targeted therapies.
Researchers have developed advanced microtissues that mimic the human spinal cord using stem cell technology, offering promising tools for studying neurodegenerative diseases like amyotrophic lateral sclerosis (ALS). These 'spinal cord-like' microtissues are created from stem cells derived from individual patients, enabling personalized testing of disease mechanisms and potential treatments.
ALS is a rapid-progressing neurodegenerative disorder characterized by the loss of motor neurons in the spinal cord, leading to muscle paralysis and ultimately, death within an average of three years. The molecular causes of ALS remain unclear, but neuroinflammation—a harmful overactivation of immune responses within the spinal cord—is believed to play a key role in motor neuron death.
To better understand this process, scientists from the Memorial Sloan Kettering Cancer Center, led by Elisa Giacomelli and Lorenz Studer, generated spinal microtissues containing both motor neurons and immune cells from stem cells. Their study, published in Stem Cell Reports, revealed that microtissues derived from ALS patients secreted higher levels of inflammatory proteins compared to those from healthy individuals. Over time, these ALS microtissues also showed progressive motor neuron death, accurately recreating key features of the disease.
Furthermore, the team tested 190 FDA-approved drugs on these microtissues to identify potential treatments. They discovered that a specific class of drugs could reduce inflammatory protein levels in ALS microtissues to those observed in healthy tissues, which correlated with decreased motor neuron loss. These findings suggest that these microtissues could serve as scalable platforms for high-throughput drug screening and for studying patient-specific neuroinflammatory processes in ALS.
This innovative approach opens new avenues for understanding neurodegeneration and developing targeted therapies, bringing hope for more effective treatments for ALS and similar conditions.
Source: https://medicalxpress.com/news/2025-06-stem-cell-derived-spinal-cord.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Breakthrough Genetic Research Spurs Large-Scale Diabetes Trials in Chinese Hospitals
A groundbreaking genetic study in China has led to the development of a new diagnostic tool for more accurate classification of diabetes types, paving the way for large-scale clinical trials and personalized treatment approaches.
New Insights into How Gut Microbes Trigger Immune Tolerance via Bacterial Sensor STING
Discover how the bacterial sensor protein STING plays a pivotal role in promoting immune tolerance to gut microbes, offering new insights into intestinal health and potential treatments for inflammatory bowel disease.
Emerging Tuberculosis Case Raises Public Health Concerns in Northern California
A recent case of contagious tuberculosis at a popular California casino has prompted health officials to conduct contact tracing, highlighting the ongoing risk and resurgence of TB in the region. Learn about symptoms, transmission, and prevention.
New Study Connects Pesticide Exposure to Increased Mortality in Children
A groundbreaking study links prenatal pesticide exposure to higher mortality risk in children with leukemia, highlighting the urgent need to reduce environmental toxicants affecting children's health.